NCT04647084

Brief Summary

IV placement is necessary for surgical procedures. Unfortunately, some patients say that placing an IV is painful. The investigators are conducting this study to evaluate two techniques that could make the placement of the IV more comfortable.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2022

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 30, 2020

Completed
1.9 years until next milestone

Study Start

First participant enrolled

October 15, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

August 18, 2023

Status Verified

October 1, 2022

Enrollment Period

2 years

First QC Date

November 17, 2020

Last Update Submit

August 16, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain with IV Cannulation based on the Visual Analog Scale

    How much pain do adult patients experience with peripheral IV cannulation when Buzzy® device is used versus when intradermal lidocaine 2% is used? The Visual Analog Scale is used for linear measurement of pain, where the minimum number is 0 (no pain) and the maximum number is 10 (unimaginable pain).

    5-20 minutes

Secondary Outcomes (4)

  • Satisfaction with IV cannulation based on the Numerical Rating Scale

    5-20 minutes

  • Number of IV cannulation attempts

    5-20 minutes

  • Pain related to IV size based on the Visual Analog Scale

    5-20 minutes

  • Pain related to IV location based on the Visual Analog Scale

    5-20 minutes

Study Arms (2)

Intradermal Lidocaine 2%

EXPERIMENTAL
Drug: Lidocaine 2% Injectable Solution

Buzzy

EXPERIMENTAL
Device: Buzzy

Interventions

An elastic band will be placed around the subject's arm, and the elastic band will be removed once the IV is inserted. After the elastic band is placed on the subject's arm, the arm will be cleaned, and then a small skin wheel will be created with the lidocaine that will be injected very close to where the IV will be placed. The IV will be placed within about a minute from the time when the lidocaine was injected.

Intradermal Lidocaine 2%
BuzzyDEVICE

The Buzzy vibrating ice pack will be placed on the subject's arm with an elastic band around it, and it will remain there as the arm is cleaned and prepped and the IV inserted. The Buzzy device will be removed once the IV is inserted.

Buzzy

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults ages 18 to 99
  • Non-pregnant women and men
  • Adults that are able to consent
  • Patients requiring intravenous catheter insertion for their operation/procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Elizabeth's Medical Center

Brighton, Massachusetts, 02135, United States

Location

MeSH Terms

Conditions

Acute PainPatient Satisfaction

Interventions

Lidocaine

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Michael Schoor, MD

    physician

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2020

First Posted

November 30, 2020

Study Start

October 15, 2022

Primary Completion

October 15, 2024

Study Completion

May 31, 2025

Last Updated

August 18, 2023

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations